Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis

Journal of Hepatology

Volumn 59, Issue 2, 2013, Pages 265-270

  Tripodi, Armando ^a,b   Primignani, Massimo ^b   Lemma, Laura ^a,b   Chantarangkul, Veena ^a,b   Mannucci, Pier Mannuccio ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Factor VIII; Protac ; Thrombin generation; Thrombomodulin

Indexed keywords

PROTACTINIUM; PROTEIN C; THROMBIN; THROMBOMODULIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CLINICAL ARTICLE; FEMALE; HUMAN; IN VITRO STUDY; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PURIFICATION; THROMBIN TIME;

ENDOGENOUS THROMBIN POTENTIAL; ETP; FACTOR VIII; PICI; PROTAC®; PROTAC®-INDUCED-COAGULATION INHIBITION; THROMBIN GENERATION; THROMBOMODULIN;

AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PEPTIDES; PROTEIN C; PROTEIN C DEFICIENCY; RISK FACTORS; THROMBIN; THROMBOMODULIN; VENOUS THROMBOEMBOLISM;

EID: 84880304219     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.03.036     Document Type: Article

References (37)

1. A. Tripodi, and P.M. Mannucci Mechanisms of disease. The coagulopathy of chronic liver disease N Engl J Med 365 2011 147 156
2. A. Tripodi, F. Salerno, V. Chantarangkul, M. Clerici, M. Cazzaniga, and M. Primignani Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests Hepatology 41 2005 553 558
3. A. Tripodi, M. Primignani, V. Chantarangkul, M. Clerici, A. Dell'Era, and F. Fabris Thrombin generation in patients with cirrhosis: the role of platelets Hepatology 44 2006 440 445
4. A. Tripodi, M. Primignani, V. Chantarangkul, A. Dell'Era, M. Clerici, and R. de Franchis An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis Gastroenterology 137 2009 2105 2111
5. T. Lisman, K. Bakhtiari, I.T. Pereboom, H.G. Hendriks, J.C. Meijers, and R.J. Porte Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests J Hepatol 52 2010 355 361
6. A. Tripodi, M. Primignani, L. Lemma, V. Chantarangkul, A. Dell'Era, and F. Iannuzzi Detection of the imbalance of pro- vs. anti-coagulant factors in cirrhosis by a simple laboratory method Hepatology 52 2010 249 255
7. A. Gatt, A. Riddell, V. Calvaruso, E. Tuddenham, M. Makris, and A.K. Burroughs Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy J Thromb Haemost 8 2010 1994 2000
8. P.G. Northup, M.M. McMahon, A.P. Ruhl, S.E. Altschuler, A. Volk-Bednarz, and S.H. Caldwell Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism Am J Gastroenterol 101 2006 1524 1528
9. K.K. Søgaard, E. Horváth-Puhó, H. Grønbaek, P. Jepsen, H. Vilstrup, and H.T. Sørensen Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study Am J Gastroenterol 104 2009 96 101
10. E. Villa, C. Cammà, M. Marietta, M. Luongo, R. Critelli, and S. Colopi Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis Gastroenterology 143 2012 1253 1260
11. H.C. Hemker, P. Giesen, R. Al Dieri, V. Regnault, E. de Smedt, and R. Wagenvoord Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 2003 4 15
12. V. Chantarangkul, M. Clerici, A. Bressi, P.L. Giesen, and A. Tripodi Thrombin generation assessed as endogenous thrombin potential (ETP) in patients with hypo- or hyper-coagulability. Effects of phospholipids, tissue factor and residual platelets on the measurement performed in platelet-poor and platelet-rich plasma Haematologica 88 2003 547 554
13. P. Toulon, M. Smirnov, M. Triscott, O. Safa, E. Biguzzi, and K. Bouziane A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study Thromb Res 124 2009 137 143
14. K.G. Mann, T. Orfeo, S. Butenas, A. Undas, and K. Brummel-Ziedins Blood coagulation dynamics in haemostasis Hamostaseologie 29 2009 7 16
15. B. Dahlback Progress in the understanding of the protein C anticoagulant pathway Int J Hematol 79 2004 109 116
16. M.J. Hollestelle, H.G. Geertzen, I.H. Straatsburg, T.M. van Gulik, and J.A. van Mourik Factor VIII expression in liver disease Thromb Haemost 91 2004 267 275
17. A. Tripodi, Q.M. Anstee, K.K. Sogaard, M. Primignani, and D.C. Valla Hypercoagulability in cirrhosis: causes and consequences J Thromb Haemost 9 2011 1713 1723
18. D.C. Valla Thrombosis and anticoagulation in liver disease Hepatology 47 2008 1384 1393
19. K. Okuda, K. Ohnishi, K. Kimura, S. Matsutani, M. Sumida, and N. Goto Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients Gastroenterology 89 1985 279 286
20. C. Francoz, J. Belghiti, V. Vilgrain, D. Sommacale, V. Paradis, and B. Condat Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation Gut 54 2005 691 697
21. J. Lendoire, G. Raffin, N. Cejas, F. Duek, P. Barros Schelotto, and P. Trigo Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome HPB (Oxford) 9 2007 352 356
22. M.A. Yerdel, B. Gunson, D. Mirza, K. Karayalçin, S. Olliff, and J. Buckels Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome Transplantation 69 2000 1873 1881
23. L. Lladó, J. Fabregat, J. Castellote, E. Ramos, J. Torras, and R. Jorba Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality Clin Transplant 21 2007 716 721
24. C. Kearon, S.R. Kahn, and G. Agnelli Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 454S 545S
25. M.A. Zocco, E. Di Stasio, R. De Cristofaro, M. Novi, M.E. Ainora, and F. Ponziani Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development J Hepatol 51 2009 682 689
26. M. Primignani Portal vein thrombosis, revisited Dig Liver Dis 42 2010 163 170
27. L.P. Bechmann, M. Wichert, K. Kröger, and P. Hilgard Dosing and monitoring of low-molecular-weight heparin in cirrhotic patients Liver Int 31 2011 1064
28. T. Lisman, and R.J. Porte Towards a rational use of low-molecular-weight heparin in patients with cirrhosis Liver Int 31 2011 1063
29. M. Senzolo Rodriguez Kryssia I, Rossetto V, Radu C, Gavasso S, Carraro P3, Zerbinati P, Sartori MT, Simioni P. Increased anticoagulant response to low molecular weitgh heparin in plasma from patients with advanced cirrohisis J Thromb Haemost 10 2012 1823 1829
30. S. Schulman, C. Kearon, A.K. Kakkar, P. Mismetti, S. Schellong, and H. Eriksson Dabigatran versus warfarin in the treatment of acute venous thromboembolism N Engl J Med 361 2009 2342 2352
31. R. Bauersachs, S.D. Berkowitz, B. Brenner, H.R. Buller, H. Decousus, and A.S. Gallus Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 363 2010 2499 2510
32. The EINSTEIN-PE Investigators Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N Engl J Med 366 2012 1287 1297
33. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
34. M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, and W. Hacke Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
35. C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, and M. Hanna Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
36. S.J. Connolly, J. Eikelboom, C. Joyner, H.C. Diener, R. Hart, and S. Golitsyn Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
37. E.A. Tsochatzis, J. Bosch, and A.K. Burroughs A new paradigm for patients with cirrhosis Hepatology 56 2012 1983 1992